Influence of insulin, sympathetic nervous system activity, and obesity on blood pressure: The Normative Aging Study

Journal of Hypertension

Volumn 14, Issue 3, 1996, Pages 301-308

  Ward, Kenneth D ^a   Sparrow, David ^a   Landsberg, Lewis ^a   Young, James B ^a   Vokonas, Pantel S ^a,b   Weiss, Scott T ^a,c,d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b BOSTON MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d CHANNING LABORATORY   (United States)

Author keywords

Blood pressure; Hypertension; Insulin; Obesity; Sympathetic nervous system

Indexed keywords

ANTIHYPERTENSIVE AGENT; CATECHOLAMINE; GLUCOSE; INSULIN; NORADRENALIN;

ADRENERGIC SYSTEM; ADULT; AGE; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; DIASTOLIC BLOOD PRESSURE; FAMILY HISTORY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; INSULIN BLOOD LEVEL; MALE; NORMAL HUMAN; OBESITY; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SMOKING; SYSTOLIC BLOOD PRESSURE; URINALYSIS; URINARY EXCRETION;

EID: 0029967740     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199603000-00005     Document Type: Article

References (59)

1. MacMahon S, Cutler J, Brittain E, Higgins M: Obesity and hypertension: epidemiological and clinical issues. Eur Heart J 1987, 8B:57-70.
2. Kannel WB, Brand N, Skinner JJ, Dawber TR, McNamara PM: The relation of adiposity to blood pressure and development of hypertension. Ann Intern Med 1967, 1:48-59.
3. Cassano PA, Segal MR, Vokonas PS, Weiss ST: Body fat distribution, blood pressure, and hypertension: a prospective cohort study of men in the normative aging study. Ann Epidemiol 1990, 1:33-48.
4. Peiris AN, Sothmann MS, Hoffmann RG, Hennes MI, Wilson CR, Gustafson AB, et al.: Adiposity, fat distribution, and cardiovascular risk. Ann Intern Med 1989, 110:867-872.
5. Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, et al.: Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982, 54:254-260.
6. Evans DJ, Hoffman RG, Kalkhoff RK, Kissebah AH: Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women. Metabolism 1984, 33:68-75.
7. Peins AN, Mueller RA, Smith GA, Struve MF, Kissebah AH: Splanchnic insulin metabolism in obesity: influence of body fat distribution. J Clin Invest 1986, 78:1648-1657.
8. Freedman DS, Srinivasan SR, Burke GL, Shear CL, Smoak CG, Harsha DW, et al.: Relation of body fat distribution to hyperinsulinemia in children and adolescents: the Bogalusa Heart Study. Am J Clin Nutr 1987, 46:403-410.
9. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, et al.; Insulin resistance in essential hypertension. N Engl J Med 1987, 317:350-357.
10. Salvatore T, Cozzolino D, Giunta R: Decreased insulin clearance as a feature of essential hypertension. J Clin Endocrinol Metab 1992, 74:144-149.
11. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, et al.: Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 1989, 320:702-706.
12. Shen DC, Shieh SM, Fuh MM, Wu DA, Chen YD, Reaven GM: Resistance to insulin-stimulated-glucose uptake in patients with hypertension. J Clin Endocrinol Metab 1988, 66:580-583.
13. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, et al.: Hyperinsulinemia: a link between hypertension obesity and glucose intolerance. J Clin Invest 1985, 75:809-817.
14. Haffner SM, Fong D, Hazuda HP, Pugh JA, Patterson JK: Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetes. Metabolism 1988, 37:338-345.
15. Cambien F, Warnet JM, Eschwege E, Jacqueson A, Richard JL, Roselin G: Body mass, blood pressure, glucose, and lipids: does plasma insulin explain their relationship? Arteriosclerosis 1987, 7:197-202.
16. Baum M: Insulin stimulates volume absorption in the rabbit proximal convoluted tubule. J Clin Invest 1987, 79:1104-1109.
17. DeFronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ: The effect of insulin on renal handling of sodium, potassium, calcium and phosphate in man. J Clin Invest 1975, 55:845-855.
18. Rocchini AP, Key J, Bondie D, Chico R, Moorehead C, Katch V, et al.: The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med 1989, 321:580-585.
19. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L: Effect of insulin and glucose infusions on sympathetic nervous system activity in normal men. Diabetes 1981, 30:219-225.
20. O'Hare JA, Minaker K, Young JB: Insulin increases plasma norepinephrine (NE) and lowers plasma potassium equally in lean and obese men [abstract]. Clin Res 1985, 33:441A.
21. Landsberg L, Troisi R, Parker D, Young JB, Weiss ST: Obesity, blood pressure and the sympathetic nervous system. Ann Epidemiol 1991, 1:295-303.
22. Solvt VB, Brown MR, Kennedy B, Kolterman OG, Ziegler MG: Elevated insulin, norepinephrine, and neuropeptide Y in hypertension. Am J Hypertens 1990, 3:823-828.
23. Bell B, Rose CL, Damon A: The Normative Aging Study: an interdisciplinary and longitudinal study of health and aging. Aging Hum Dev 1972, 3:5-17.
24. Smedes F, Kraak JC, Poppe H: Simple and fast solvent extraction system for selective and quantitative isolation of adrenaline, noradrenaline, and dopamine from plasma and urine. J Chromatogr 1982, 231:25-39.
25. MacDonald IA, Lake DM: An improved technique for extracting catecholamines from body fluids. J Neurosci Meth 1985, 13:239-248.
26. Leon LP, Chu DK, Stasiw RP: New more specific methods for the SMA 12/60 multichannel biochemical analyzer. In Advances in Automated Analysis Technicon International Congress, 1976. Tarrytown, NY: Mediad, Inc.; 1977: 1.
27. Paffenbarger RS, Hyde RT, Wing AL, Hsieh CC: Physical activity, all cause mortality and longevity of college alumni. N Engl J Med 1986, 314:605-613.
28. SAS Institute: ASS User's Guide: Statistics. Version 5. Cary, NC: SAS Institute, Inc., 1985.
29. Troisi RJ, Weiss ST, Parker DR, Sparrow D, Young JB, Landsberg L: Relation of obesity and diet to sympathetic nervous system activity. Hypertension 1991, 17:669-677.
30. Philipp TH, Distler A, Cordes U: Sympathetic nervous system and blood-pressure control in essential hypertension. Lancet 1978, II:959-963.
31. deChamplain J, Farley L, Cousineau D, van Ameringen MR: Circulating catecholamine levels in human and experimental hypertension. Circ Res 1976, 38:109-114.
32. Goldstein PS: Plasma catecholamines and essential hypertension, an analytical review. Hypertension 1983, 5:86-99.
33. Kushiro T, Kobayashi F, Osada H, Tomiyama H, Sato K, Otsuka Y, et al.; Role of sympathetic activity in blood pressure reduction with low calorie regimen. Hypertension 1991, 17:965-968.
34. Sowers JR, Nyby M, Stern N, Beck F, Baron S, Catania R, et al.: Blood pressure and hormone changes associated with weight reduction in the obese. Hypertension 1982, 4:686-691.
35. Sowes JR, Whitfield LA, Catania RA, Stem N, Tuck ML, Dornfeld L, et al.: Role of the sympathetic nervous system in blood pressure maintenance in obesity. J Clin Endocrinol Metab 1982, 54:1181-1186.
36. Pollare T, Lithell H, Berne C: Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 1990, 39:167-174.
37. Christlieb AR, Krolewski AS, Warram JH, Soeldner JS: Is insulin the link between hypertension and obesity? Hypertension 1985, 7 (suppl II):II54-II57.
38. Manicardi V, Camellini L, Bellodi G, Coscelli C, Ferrannini E: Evidence for an association of high blood pressure and hyperinsulinemia in obese man. J Clin Endocrinol Metab 1986, 62:1302-1304.
39. Lucas CP, Estigarribia JA, Darga LL, Reaven GM: Insulin and blood pressure in obesity. Hypertension 1985, 7:702-706.
40. Denker PS, Pollock VE: Fasting serum insulin levels in essential hypertension. Arch Intern Med 1992, 152:1649-1651.
41. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH: Insulin and hypertension, relationship to obesity and glucose intolerance in Pima Indians. Diabetes 1990, 39:1430-1435.
42. Mitchell BD, Haffner SM, Hazuda HP, Valdez R, Stern MP: The relation between serum insulin levels and 8-year changes in lipid, lipoprotein, and blood pressure levels. Am J Epidemiol 1992, 136:12-22.
43. Saad MF, Lillioja S, Nyomba BL, Castillo C, Ferraro R, DeGregorio M, et al.: Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 1991, 324:733-739.
44. Wing RR, Bunker CH, Kuller LH, Matthews KA: Insulin, body mass index, and cardiovascular risk factors in premenopausal women. Arteriosclerosis 1989, 9:479-484.
45. Donahue RP, Orchard TJ, Becker DJ, Kuller LH, Drash AL: Sex differences in the coronary heart disease risk profile: a possible role for insulin. The Beaver County Study. Am J Epidemiol 1987, 125:650-657.
46. Lucas CP, Estigarribia JA, Darga LL, Reaven GM: Insulin and blood pressure in obesity. Hypertension 1985, 7:702-706.
47. Bonora E, Zavaroni I, Alpi O, Ellsinger BM, DiBiase G, Bjorntorp P, et al.: Relationship between blood pressure and plasma insulin in non-obese and obese non-diabetic subjects. Diabetologia 1987, 30:719-723.
48. Troisi RJ, Weiss ST, Segal MR, Cassano PA, Vokonas PS, Landsberg L: The relationship of body fat distribution to blood pressure in normotensive men: the Normative Aging Study. Int J Obes 1990, 14:515-525.
49. Blair D, Habicht JP, Sims EAH, Sylwester D, Abraham S: Evidence for an increased risk for hypertension with centrally located body fat and the effect of race and sex on this risk. Am J Epidemiol 1984, 119:526-540
50. Selby JV, Friedman GD, Quesenberry CP: Precursors of essential hypertension, the role of body fat distribution pattern. Am J Epidemiol 1989, 129:43-53.
51. Kalkhoff RK, Hartz AH, Rupley D, Kissebah AH, Kelber S: Relationship of body fat distribution to blood pressure, carbohydrate tolerance and plasma lipids in healthy obese women. J Lab Clin Med 1983, 102:621-627.
52. Cigolini M, Seidell JC, Charzewska J, Ellsinger BM, DiBiase G, Bjorntorp P, et al.: Fasting serum insulin in relation to fat distribution, serum lipid profile, and blood pressure in European women: the European fat distribution study. Metabolism 1991, 40:781-787.
53. Landsberg L: Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. Q J Med 1986, 236:1081-1090.
54. Landsberg L: Obesity and hypertension: experimental data. J Hypertens 1992, 10 (suppl 7):S195-S201.
55. Landsberg L: Pathophyslology of obesity-related hypertension: role of Insulin and the sympathetic nervous system. J Cardiovasc Pharmacol 1994, 23 (suppl 1):S1-S8.
56. Muntzel MS, Anderson EA, Johnson AK, Mark AL: Mechanisms of insulin action on sympathetic nerve activity. Clin Exp Hypertens 1995, 17:39-50.
57. Jamerson KA, Smith SD, Amerena JV, Grant E, Julius S: Vasoconstriction with norepinephrine causes less forearm insulin resistance than a reflex sympathetic vasoconstriction. Hypertension 1994, 23:1006-1011.
58. Julius S: Abnormalities of an automatic control in human hypertension. Cardiovasc Drugs Ther 1994, 8 (suppl 1):11-20.
59. Modan M, Halkin H: Hyperinsulilnemia or Increased sympathetic drive as links for obesity and hypertension. Diabetes Care 1991, 14:470-487.